Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Biosimilars

Business & Regulation Business Practice

Pacesetting Leadership

| Kiran Mazumdar-Shaw

Kiran Mazumdar-Shaw shares the experiences that have helped shape her career, and the lessons learned along the way.

Business & Regulation Business Practice

Biosimilars’ 2020 Breakthrough?

| Stephanie Sutton

The FDA has approved its first biosimilar of 2020: Pfizer’s Nyvepria (pegfilgrastim-apgf).

Manufacture Biosimilars

New Decade, New Hope

| Stephanie Sutton

Cures for all presents a real focus for the next decade – but companies must be rewarded for their work.

Manufacture Technology and Equipment

The Future of Biopharma – Big Needs and Smart Solutions

| Günter Jagschies, Soon Jae Park

We must never forget unmet needs when developing new medicines.

Business & Regulation Small Molecules

And for 2020...

| Stephanie Sutton

Nominations are now open for The Medicine Maker 2020 Power List.

Manufacture Biosimilars

It’s Complicated

| Bérangère Tissot

The potential market for complex generics is substantial, but navigating the FDA’s guidance for proving “sameness” is a real minefield...

Manufacture Biosimilars

The Good and the Bad of Biosimilars

| Sponsored by GE Healthcare

The biosimilars market is suddenly booming, but such steep competition means that only the wise will survive.

Manufacture Biosimilars

The CHO’s Over: An Inflexion Point

| Mark Emalfarb

Global healthcare costs and demands are changing, and it’s time to look beyond mammalian cell lines.

Manufacture Business Practice

Business-in-Brief

| Stephanie Sutton

After many years of clinical trial failures in Alzheimer’s disease, pharma sees some positive results – although caution is recommended.

Manufacture Biosimilars

For Patients, Not Profits

| Stephanie Sutton

A new not-for-profit company will manufacture important generics in the US

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register